
Vobose 0.3 Tablet
Marketer
USV Ltd
Salt Composition
Voglibose (0.3mg)
Overview Vobose 0.3 Tablet
Diabetase 0.3mg tablets manage type 2 diabetes by regulating post-prandial hyperglycemia. This medication is prescribed when dietary adjustments and other similar treatments prove insufficient to control elevated blood glucose. Administer Diabetase 0.3mg immediately prior to meals; dosage and frequency are determined by your physician for optimal glycemic control. Discontinue use only under medical supervision; abrupt cessation may trigger dangerously high blood sugar, potentially resulting in severe complications like renal impairment and visual loss. This medication is one component of a comprehensive treatment strategy including diet modification, physical activity, and weight management as directed by your doctor. Regular blood glucose monitoring is essential during treatment. Commonly reported adverse effects include abdominal discomfort, bloating, anorexia, bowel irregularity, and diarrhea. Report any persistent or troublesome side effects to your physician. While Diabetase 0.3mg alone doesn't induce hypoglycemia, concurrent use with other antidiabetic agents (particularly insulin or sulfonylureas) may increase this risk. Treat hypoglycemic episodes with plain glucose; sucrose is ineffective in this context. Inform your doctor of any pre-existing liver or kidney conditions before commencing treatment. This medication is contraindicated in patients with bowel inflammation or ulceration (e.g., Crohn's disease, ulcerative colitis). Consult your physician before using this medication during pregnancy or breastfeeding. Always disclose all medications you are taking to ensure treatment safety. Limit alcohol consumption while on Diabetase 0.3mg to minimize hypoglycemic risk.
Primary Ingredients of Vobose 0.3 Tablet
No text provided. Please provide the text you wish me to rephrase.
Uses of Vobose 0.3 Tablet
Managing type 2 diabetes
Major Benefits of Vobose 0.3 Tablet:
Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and treatment length. Ingest the Vobose 0.3 Tablet whole; avoid chewing, crushing, or fracturing it. Administer on an empty stomach.
Common Side effects of Vobose 0.3 Tablet:
- Skin rash
- Flatulence
- Abdominal pain
- Diarrhea
How to use Vobose 0.3 Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Vobose 0.3 Tablet whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.
How Vobose 0.3 Tablet works:
Glucovance 0.3mg tablets manage diabetes by blocking enzymes in the intestines that digest complex carbohydrates. This action reduces post-meal spikes in blood sugar.
SAFETY ADVICE
AlcoholUNSAFE
Combining Vobose 0.3 Tablet with alcohol is inadvisable.
PregnancySAFE IF PRESCRIBED
The use of Vobose 0.3 Tablet during pregnancy is typically deemed safe. Preclinical trials in animals have revealed minimal or no negative consequences for fetal development; nevertheless, data from human studies are scarce.
Breast feedingSAFE IF PRESCRIBED
The use of Vobose 0.3 Tablet while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Vobose 0.3 Tablet.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Vobose 0.3 Tablets. Dosage modification of Vobose 0.3 Tablets may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should exercise caution when using Vobose 0.3 Tablet; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Vobose 0.3 Tablet :
Omit any missed Vobose 0.3 Tablet dose and resume your regular medication regimen. Avoid taking a double dose.
Facts to Know About Vobose 0.3 Tablet
| Label | Value |
|---|---|
| Chemical Classification | Valiolamine analog |
| Developing Habits | No. |
| Treatment Category | Diabetes Medication |
| Behavior Class | Alpha-glucosidase inhibitors |
